CNS Pharmaceuticals announces a $1.98M registered direct offering of 1.425M shares.
CNS Pharmaceuticals announced a registered direct offering, selling 1.425M shares of common stock at $1.39 each and warrants to buy the same amount of shares. Institutional investors prompted a 73.8% increase in stock price, leading to a trading volume of 55.7M shares. The offering aims to raise $1.98M before expenses for working capital and general corporate purposes.
July 03, 2024
5 Articles